| Literature DB >> 27783239 |
Hiroshi Miyakita1, Sotaro Sadahiro2, Gota Saito1, Kazutake Okada1, Akira Tanaka1, Toshiyuki Suzuki1.
Abstract
BACKGROUND: Rectal cancer is associated with a higher rate of surgical complications. The ability to predict the risk of complications before treatment would facilitate the design of personalized treatment strategies optimally suited for each patient.Entities:
Keywords: Anastomotic leakage; Complication; Rectal cancer; Risk score
Mesh:
Year: 2016 PMID: 27783239 PMCID: PMC5378746 DOI: 10.1007/s10147-016-1054-1
Source DB: PubMed Journal: Int J Clin Oncol ISSN: 1341-9625 Impact factor: 3.402
Patients’ characteristics
| Variable |
|
|---|---|
| Sex | |
| Male | 190 (73) |
| Female | 70 (28) |
| Age (year) | |
| Range | 28–92 |
| Median | 63 |
| Location of the tumor | |
| Upper and middle | 112 (43) |
| Lower | 148 (57) |
| Neoadjuvant CRT | |
| Yes | 202 (77) |
| No | 58 (23) |
| Concurrent chemotherapy | |
| UFT | 37 (19) |
| S-1 | 165 (81) |
| Radiation | |
| 40 or 45 Gy | 183 (91) |
| 20 Gy and IOR | 19 (9) |
| Surgical procedure | |
| LAR | 187 (70) |
| APR | 73 (30) |
| Histological type | |
| Well | 129 (50) |
| Moderate | 92 (35) |
| Poor | 1 (0.3) |
| Mucinous | 12 (5) |
| pCR | 26 (10) |
| Lymphatic invasion | |
| Positive | 121 (46) |
| Negative | 138 (53) |
| Unknown | 1 (0.3) |
| Venous invasion | |
| Positive | 126 (48) |
| Negative | 133 (51) |
| Unknown | 1 (0.3) |
| Pathological stage (include ypStage) | |
| 0 | 29 (11) |
| I | 79 (30) |
| II | 78 (31) |
| III | 73 (28) |
CRT chemoradiotherapy; LAR: low anterior resection; APR abdominoperineal resection; pCR pathological complete response
Postoperative complications according to the Cravien-Dindo grade
| Complication | C–D grade |
|
|---|---|---|
| Infectious complication | 3a | 18 (27.6) |
| 3b | 1 (1.5) | |
| 4 | 0 (0) | |
| Anastomotic leakage | 3a | 6 (27.2) |
| 3b | 11 (55.0) | |
| 4 | 1 (5.0) | |
| Bowel obstruction | 3a | 8 (26.6) |
| 3b | 8 (26.6) | |
| 4 | 0 (0) |
C–D grade Cravien-Dindo grade
Univariate analysis of anastomotic leakage
| Variable | Patients with leakage | Patients without leakage |
| |
|---|---|---|---|---|
| Sex | ||||
| Male | 11 | 122 | ||
| Female | 1 | 53 | 0.1045 | |
| Age | ||||
| Range | 43–77 | 28–92 | ||
| Median | 64.5 | 63 | 0.5691 | |
| BMI | ||||
| ≥25 | 4 | 32 | ||
| <25 | 8 | 143 | 0.2009 | |
| Smoking history | ||||
| No | 4 | 86 | ||
| Yes | 8 | 89 | 0.3168 | |
| Location of the tumor | ||||
| Upper or middle | 7 | 104 | ||
| Lower | 5 | 71 | 0.9404 | |
| pStage | ||||
| 0 | 4 | 21 | ||
| I | 3 | 54 | ||
| II | 2 | 49 | ||
| III | 3 | 51 | 0.2083 | |
| CRT | ||||
| No | 2 | 40 | ||
| Yes | 10 | 135 | 0.6191 | |
| E-PASS CRS | ||||
| <0.294 | 4 | 104 | ||
| ≥0.294 | 8 | 71 | 0.0767 | |
| NLR | ||||
| <2.21 | 2 | 86 | ||
| ≥2.21 | 10 | 89 | 0.0292 | |
BMI body mass index, CRT chemoradiotherapy, E-PASS CRS Estimation of Physiologic Ability and Surgical Stress Comprehensive Risk Score, NLR neutrophilic lymphocytes ratio
Multivariate logistic regression analysis of anastomotic leakage
| OR | 95% CI |
| |
|---|---|---|---|
| Sex | |||
| Female | Reference | ||
| Male | 3.66 | 0.60–71.08 | 0.1778 |
| BMI | 1.31 | 1.02–1.72 | 0.0775 |
| Smoking history | |||
| No | Reference | ||
| Yes | 1.76 | 0.47–7.72 | 0.4018 |
| Location of the tumor | |||
| Upper or middle | Reference | ||
| Lower | 1.59 | 0.42–6.61 | 0.4903 |
| CRT | |||
| No | Reference | ||
| Yes | 2.13 | 0.42–16.82 | 0.3808 |
| pStage | |||
| 0 | Reference | ||
| 1 | 5.44 | 0.59–60.06 | 0.1317 |
| 2 | 7.60 | 0.90–84.88 | 0.0617 |
| 3 | 4.92 | 0.61–48.42 | 0.1322 |
| E-PASS CRS | |||
| <0.294 | Reference | ||
| ≥0.294 | 6.85 | 1.63–39.63 | 0.0075 |
| NLR | |||
| <2.21 | Reference | ||
| ≥2.21 | 8.24 | 1.61–76.07 | 0.0089 |
OR odds ratio, 95 % CI 95% confidence interval, BMI body mass index, CRT chemoradiotherapy, E-PASS CRS Estimation of Physiologic Ability and Surgical Stress Comprehensive Risk Score, NLR neutrophilic lymphocytes ratio
Accuracy rate of anastomotic leakage according to predictive scoring systems
| Score | COV | OR | 95% CI |
| Accuracy rate (%) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|---|---|---|---|---|
| E-PASS CRS | 0.294 | 4.38 | 1.28–17.46 | 0.0183 | 68.4 | 66.6 | 68.6 | 20.5 | 94.4 |
| PNI | 40 | 1.75 | 0.48–6.35 | 0.3907 | 27.0 | 66.6 | 22.2 | 9.4 | 84.6 |
| NLR | 2.21 | 4.51 | 1.11–30.38 | 0.0329 | 51.3 | 83.3 | 47.4 | 16.1 | 95.9 |
| SAS | 5 | 0 | – | 0.5410 | 13.5 | 100 | 96.9 | 11.0 | 100 |
| CR-POSSUM | 18 | 1.30 | 0.37–4.24 | 0.6660 | 34.2 | 58.3 | 31.3 | 9.3 | 86.1 |
COV cut off value; OR odds ratio; 95 % CI 95% confidence interval; PPV positive predictive value; NPV negative predictive value; E-PASS CRS Estimation of Physiologic Ability and Surgical Stress Comprehensive Risk Score; SAS Surgical Apgar Score; PNI Onodera’s prognostic nutritional index; NLR neutrophilic lymphocytes ratio; CR-POSSUM Colorectal physiological and operative severity score for the enumeration of mortality and morbidity
Relation between the predictive scoring systems and the incidence of complication
| Complication | Cut-off value | Incidence (%) | OR | 95% CI |
|
|---|---|---|---|---|---|
| E-PASS CRS | |||||
| All complication | <0.294 | 16/134 (11.9) | Reference | ||
| ≥0.294 | 40/126 (31.7) | 3.45 | 1.84–6.73 | <0.0001 | |
| Infectious complication | <0.294 | 5/134 (3.7) | Reference | ||
| ≥0.294 | 14/126 (11.1) | 3.23 | 1.19–10.23 | 0.0202 | |
| Anastomotic leakage | <0.294 | 4/72 (5.5) | Reference | ||
| ≥0.294 | 8/39 (20.5) | 4.38 | 1.28–17.46 | 0.0183 | |
| Bowel obstruction | <0.294 | 5/134 (3.7) | Reference | ||
| ≥0.294 | 11/126 (8.7) | 2.46 | 0.86–8.02 | 0.0906 | |
| PNI | |||||
| All complication | ≥41 | 29/179 (16.1) | Reference | ||
| <40 | 27/81 (33.3) | 2.60 | 1.41–4.80 | 0.0022 | |
| Infectious complication | ≥41 | 12/179 (6.7) | Reference | ||
| <40 | 7/81 (8.6) | 1.32 | 0.47–3.42 | 0.5750 | |
| Anastomotic leakage | ≥41 | 8/85 (9.4) | Reference | ||
| <40 | 4/26 (15.4) | 1.75 | 0.48–6.35 | 0.3907 | |
| Bowel obstruction | ≥41 | 7/179 (3.9) | Reference | ||
| ≥40 | 9/81 (11.1) | 3.08 | 1.10–8.94 | 0.0311 | |
| NLR | |||||
| All complication | <2.21 | 17/123 (13.8) | Reference | ||
| ≥2.21 | 39/137 (28.5) | 2.50 | 1.35–4.81 | 0.0033 | |
| Infectious complication | <2.21 | 4/123 (3.2) | Reference | ||
| ≥2.21 | 15/137 (10.9) | 3.65 | 1.28–13.11 | 0.0138 | |
| Anastomotic leakage | <2.21 | 10/62 (16.1) | Reference | ||
| ≥2.21 | 2/49 (4.08) | 4.51 | 1.11–30.38 | 0.0329 | |
| Bowel obstruction | <2.21 | 5/123 (4.0) | Reference | ||
| ≥2.21 | 11/137 (8.0) | 2.06 | 0.69–6.10 | 0.1842 | |
| Surgcal apgar score | |||||
| All complication | ≥5 | 48/239 (20.0) | Reference | ||
| <5 | 8/21 (38.1) | 2.46 | 0.92–6.18 | 0.0692 | |
| Infectious complication | ≥5 | 14/239 (5.8) | Reference | ||
| <5 | 5/21 (23.8) | 5.02 | 1.47–15.09 | 0.0119 | |
| Anastomotic leakage | ≥5 | 12/108 (11.1) | |||
| <5 | 0/3 | – | – | 0.5410 | |
| Bowel obstruction | ≥5 | 15/239 (6.3) | Reference | ||
| <5 | 1/21 (4.8) | 0.74 | 0.09–5.94 | 0.7819 | |
| CR-POSSUM | |||||
| All complication | <18 | 18/124 (14.5) | Reference | ||
| ≥18 | 38/136 (27.9) | 2.26 | 1.22–4.29 | 0.0086 | |
| Infectious complication | <18 | 3/124 (2.4) | Reference | ||
| ≥18 | 16/136 (11.8) | 5.37 | 1.52–18.93 | 0.0038 | |
| Anastomotic leakage | <18 | 7/75 (9.3) | Reference | ||
| ≥18 | 5/36 (13.8) | 1.30 | 0.37–4.24 | 0.6660 | |
| Bowel obstruction | <18 | 5/124 (4.0) | Reference | ||
| ≥18 | 11/136 (8.1) | 2.09 | 1.73–6.81 | 0.1681 | |
OR odds ratio; 95 % CI 95% confidence interval; E-PASS CRS Estimation of Physiologic Ability and Surgical Stress Comprehensive Risk Score; SAS Surgical Apgar Score; PNI Onodera’s prognostic nutritional index; NLR neutrophilic lymphocytes ratio; CR-POSSUM colorectal physiological and operative severity score for the enumeration of mortality and morbidity